Australia - English - Department of Health (Therapeutic Goods Administration)

cipla australia pty ltd - escitalopram oxalate, quantity: 25.548 mg - tablet, film coated - excipient ingredients: croscarmellose sodium; maize starch; magnesium stearate; mannitol; microcrystalline cellulose; titanium dioxide; hypromellose; macrogol 6000 - treatment of major depression. ,treatment of social anxiety disorder (social phobia). ,treatment of generalised anxiety disorder. ,treatment of obsessive-compulsive disorder.

Australia - English - Department of Health (Therapeutic Goods Administration)

generic health pty ltd - amitriptyline hydrochloride, quantity: 10 mg - tablet - excipient ingredients: maize starch; titanium dioxide; lactose monohydrate; macrogol 6000; hypromellose; purified talc; crospovidone; colloidal anhydrous silica; brilliant blue fcf aluminium lake; magnesium stearate; microcrystalline cellulose - for the treatment of major depression. amitriptyline 50 mg tablets are indicated only for the maintenance treatment of major depression ,nocturnal enuresis where organic pathology has been excluded.

United States - English - NLM (National Library of Medicine)

medsource pharmaceuticals - amitriptyline hydrochloride (unii: 26lud4jo9k) (amitriptyline - unii:1806d8d52k) - amitriptyline hydrochloride 25 mg - for the relief of symptoms of depression. endogenous depression is more likely to be alleviated than are other depressive states. amitriptyline hydrochloride is contraindicated in patients who have shown prior hypersensitivity to it. it should not be given concomitantly with monoamine oxidase inhibitors. hyperpyretic crises, severe convulsions, and deaths have occurred in patients receiving tricyclic antidepressant and monoamine oxidase inhibiting drugs simultaneously. when it is desired to replace a monoamine oxidase inhibitor with amitriptyline hydrochloride, a minimum of 14 days should be allowed to elapse after the former is discontinued. amitriptyline hydrochloride should then be initiated cautiously with gradual increase in dosage until optimum response is achieved. amitriptyline hydrochloride should not be given with cisapride due to the potential for increased qt interval and increased risk for arrhythmia. this drug is not recommended for use during the acute recovery phase following myocardial infarc

Ireland - English - HPRA (Health Products Regulatory Authority)

clonmel healthcare ltd - ibuprofen; phenylephrine hydrochloride - film-coated tablet - 400/10 milligram(s) - other cold preparations

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - donepezil hydrochloride - film-coated tablet - 10 milligram(s) - anticholinesterases; donepezil

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - bisoprolol fumarate - film-coated tablet - 10 milligram(s) - beta blocking agents, selective; bisoprolol

Ireland - English - HPRA (Health Products Regulatory Authority)

accord healthcare ireland ltd. - escitalopram - film-coated tablet - 10 milligram(s) - selective serotonin reuptake inhibitors; escitalopram

Ireland - English - HPRA (Health Products Regulatory Authority)

lundbeck ( ireland ) limited - zuclopenthixol hydrochloride - film-coated tablet - 10 milligram(s) - thioxanthene derivatives; zuclopenthixol

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - moxonidine, quantity: 200 microgram - tablet, film coated - excipient ingredients: magnesium stearate; lactose monohydrate; crospovidone; povidone; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - apo-moxonidine (moxonidine tablets) is indicated for the treatment of hypertension.

Australia - English - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - moxonidine, quantity: 400 microgram - tablet, film coated - excipient ingredients: lactose monohydrate; povidone; magnesium stearate; crospovidone; titanium dioxide; hypromellose; iron oxide yellow; macrogol 6000; iron oxide red; macrogol 400 - apo-moxonidine (moxonidine tablets) is indicated for the treatment of hypertension.